Image

Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients

Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Gait changes in Parkinson's disease are complex, variable, and difficult to detect during short clinic assessments. The aim of this study is to collect gait measurements in Parkinson's patients through sensors in a novel shoe device, NUSHU by Magnes AG. The shoe additionally provides vibrational feedback that can potentially help gait difficulties experienced by Parkinson's patients.

Eligibility

Parkinson's Disease:

Inclusion Criteria:

  1. Male or female ≥ 18 years of age.
  2. A diagnosis of Parkinson's disease
  3. Able to give written informed consent (as determined by the investigator)
  4. Can converse in English and read and perform all study activities
  5. Has willingness and ability to comply with study requirements

Exclusion Criteria:

  1. Diagnosis of an atypical parkinsonism syndrome, drug-induced parkinsonism, essential tremor, or other diagnoses that explain movement symptoms other than PD
  2. A diagnosis of significant CNS disease other than PD such as stroke, multiple sclerosis, epilepsy
  3. Persons with disorders other than PD significantly affecting gait as determined by the investigator
  4. History of MRI brain scan indicative of clinically significant abnormality as determined by the investigator
  5. Inability to wear interventional device
  6. Unable to ambulate independently at least with assistive walking device but without additional person assistance
  7. Pregnant or planning pregnancy within study timeframe
  8. Montreal Cognitive Assessment (MoCA) score < 22 at screening
  9. Resides in a nursing home or assisted care facility

Healthy Controls:

Inclusion Criteria:

  1. Male or female ≥ 18 years of age.
  2. No neurological disease or other significant gait impairment as deemed by the study investigator

Study details
    Parkinson&#39;s Disease (PD)

NCT06975059

Weill Medical College of Cornell University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.